Yuewu Wang

Yuewu Wang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2020 in Mediators of Inflammation
Verified
Journal Article
Open access
TLTiewei Li
Tiewei Li
XLXiaojuan Li
Xiaojuan Li
YFYichuan Feng
Yichuan Feng
GDGeng Dong
Geng Dong
YWYuewu Wang
Yuewu Wang
JYJunmei Yang
Junmei Yang
Matrix metalloproteinase-9 (MMP-9) belongs to the MMP family and has been widely investigated. Excessive MMP-9 expression can enhance extracellular matrix degradation and promote plaque instability. Studies have demonstrated that MMP-9 levels are higher in vulnerable plaques than in stable plaques. Additionally, several human studies have demonstrated that MMP-9 may be a predictor of atherosclerotic plaque instability and a risk factor for future adverse cardiovascular and cerebrovascular events. MMP-9 deficiency or blocking MMP-9 expression can inhibit plaque inflammation and prevent atherosclerotic plaque instability. All of these results suggest that MMP-9 may be a useful predictive biomarker for vulnerable atherosclerotic plaques, as well as a therapeutic target for preventing atherosclerotic plaque instability. In this review, we describe the structure, function, and regulation of MMP-9. We also discuss the role of MMP-9 in predicting and preventing atherosclerotic plaque instability.

1 January 2021 in Annals of Medicine
Verified
Journal Article
Open access
XLXiaojuan Li
Xiaojuan Li
TLTiewei Li
Tiewei Li
JWJingjing Wang
Jingjing Wang
GDGeng Dong
Geng Dong
MZMin Zhang
Min Zhang
YWYuewu Wang
Yuewu Wang
Previous studies have demonstrated that blood urea nitrogen (BUN) is strongly associated with sepsis. However, no data are currently available regarding the association of BUN levels and neonatal s...

1 January 2020 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
TLTiewei Li
Tiewei Li
GDGeng Dong
Geng Dong
MZMin Zhang
Min Zhang
ZXZhe Xu
Zhe Xu
YHYidi Hu
Yidi Hu
BXBangli Xu
Bangli Xu
The neutrophil–lymphocyte ratio (NLR) is an emerging risk factor of sepsis that is receiving increasing attention. However, the relationship between NLR and the presence of sepsis in neonates is poorly studied. Here, we retrospectively recruited 1480 neonates and collected and analyzed relevant clinical and laboratory data. According to the International Pediatric Sepsis Consensus, 737 neonates were diagnosed with sepsis, and 555 neonates were suspected for having infection. Neonates with hyperbilirubinemia ( n = 188) served as controls. Neonates with sepsis had significantly elevated neutrophil counts and NLR ( P < 0.001). The proportion of neonates with sepsis increased significantly from 41.6% when NLR < 0.91 to 66.2% when NLR > 1.88 group ( P < 0.001). Multiple logistic regression analysis showed that NLR was an independent risk factor for the presence of neonatal sepsis. Receiver operating characteristic (ROC) curve analysis showed that the optimal cut‐off value NLR for predicting the presence of neonatal sepsis was 1.62 (area under curve (AUC) = 0.63, 95% CI 0.60–0.66, P < 0.001). In conclusion, our data suggest that elevated NLR levels are associated with a higher neonatal sepsis risk.

15 March 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
QZQian Zhang
Qian Zhang
FWFang Wang
Fang Wang
JLJing Liu
Jing Liu
JLJun Li
Jun Li
WZWei Zhang
Wei Zhang
YWYuewu Wang
Yuewu Wang
Background: ZhuRiHeng Drop Pill (ZRH) is a traditional Mongolian medicinal preparation. Despite its long history of use for the treatment of coronary heart disease, there have been few toxicological studies of the safety profile of ZRH.Purpose: In order to comprehensively elucidate the underlying mechanisms behind the observed toxicity of ZRH on rat livers in the 180-day repeated oral toxicity study, we conducted a comprehensive analysis by integrating transcriptomic and metabolomic data.Methods: High-resolution mass spectrometry was conducted to evaluate the constituents of ZRH. For the acute oral toxicity study, mice were administered a dose of 32 g/(kg·d) of ZRH, while rats were instead orally administered 0.934, 1.868, or 3.736 g/(kg·d) of ZRH over a 180-day period in a 180-day repeated oral toxicity study. Conventional index and organ weights/histology were then monitored to detect any potential ZRH treatment-related toxicity. To identify key genes and metabolites involved in ZRH toxicological processes, we performed transcriptomic and metabolomic analyses of liver tissue upon ZRH treatment using RNA-seq techniques, qPCR and liquid chromatography-mass spectrometry analyses.Results: A total of 60 compounds in ZRH were identified and speculated in positive and negative ion modes. Mice in the acute toxicity study exhibited no signs of ZRH-related toxicity. In a protracted oral toxicity investigation spanning 180 days, discernible elevations in liver ratios were noted in both male and female rats across all three dose cohorts, relative to the control group (p < 0.05 or p < 0.01). Upon subjecting to ZRH treatment, our transcriptomic and qPCR analyses unveiled notable upregulation of crucial genes, exemplified by Abcb1b and Cyp2b2, known for theirs involvement in liver drug transport and metabolism function. Furthermore, our untargeted metabolomic analysis provided supplementary insights, revealing significant regulation in pyrimidine metabolism, as well as alanine, aspartate, and glutamate metabolism pathways.Conclusion: Our study unveils a panoramic understanding of the temporal, dosage-specific, and gene dimensions surrounding the metabolic and transcriptional shifts induced by ZRH exposure. As we peer into the future, recommendations emerge for further exploration, encompassing aspects such as time dynamics, dosage considerations, and gene-centric avenues to enhance therapeutic efficacy.

3 July 2021 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
QZQian Zhang
Qian Zhang
JLJun Li
Jun Li
WZWen Zu
Wen Zu
HYHaisen Yang
Haisen Yang
YWYuewu Wang
Yuewu Wang
The use of metal-organic framework (MOF) platforms has been a topic of growing interest in the fields of drug delivery and bioimaging. This study was designed to develop and evaluate a novel MOF-ba...

1 July 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YLYuanhong Liao
Yuanhong Liao
JLJun Li
Jun Li
YLYuxin Li
Yuxin Li
JLJing Liu
Jing Liu
TCTingting Chen
Tingting Chen
YWYuewu Wang
Yuewu Wang
Objective: To investigate the therapeutic effects of Guanxin Qiwei dropping pills (GXQW) on atherosclerosis (AS) and to delineate the mechanisms underlying these effects.Methods: First, the chemical constituents of GXQW were identified using liquid chromatography-mass spectrometry (LC-MS). In addition, 15 batches of GXQW were used for fingerprint determination. Subsequently, an ApoE−/− mouse model of AS induced by a high-fat diet was established. Lipid deposition, plaque coverage, and collagen fiber content in the aortic arch were evaluated using Oil Red O, H&E, and Masson’s trichrome staining, respectively. Enzyme-linked immunosorbent assay (ELISA) kits were employed to quantify serum oxidative stress markers, inflammatory cytokines, and lipid profiles. Additionally, fecal samples were subjected to 16S rRNA sequencing to investigate the effects of GXQW on intestinal dysbacteriosis. Differential gut microbiota were identified at the phylum-to-genus level. Furthermore, untargeted serum metabolomics was conducted to explore the potential metabolic pathways through which GXQW ameliorated AS.Results: A total of 118 chemical constituents were identified in GXQW through database comparison. Compared to the model group, GXQW treatment attenuated lipid deposition and plaque coverage in the aortic arch and mitigated collagen depletion. Fingerprint analysis showed the consistency and stability of the quality of GXQW. Additionally, GXQW reduced total cholesterol (TC) and triglyceride (TG) levels, decreased the concentrations of inflammatory cytokines interleukin-6 (IL-6) and interleukin-1beta (IL-1β), suppressed malondialdehyde (MDA) activity, and elevated superoxide dismutase (SOD) levels. In terms of gut microbiota modulation, high-dose GXQW treatment promoted the abundance of Bacteroidota and decreased Firmicutes, particularly the Dubosiella genus within Firmicutes. KEGG pathway enrichment analysis of serum metabolites revealed that pathways associated with lipid metabolism, including Glycerophospholipid metabolism, Citric acid cycle (TCA cycle), and Arachidonic acid metabolism, were notably enriched. P-cresol sulfate (PCS) and other metabolites were identified as the potential metabolic biomarkers underlying the therapeutic effects of GXQW on AS. The correlation analysis further demonstrated a significant positive correlation between Dubosiella and the aforementioned metabolites.Conclusion: The findings suggest that GXQW exerts evident therapeutic effects on AS by regulating gut microbiota and serum metabolic biomarkers.